(Q47612450)

4 February 2018

title

Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway (English)

1 reference

4 February 2018

0 references

1 reference

1 reference

Anthony F Tramontano

1

1 reference

4 February 2018

Ranganath Muniyappa

2

1 reference

4 February 2018

Aislinn D Black

3

1 reference

4 February 2018

Mihaela C Blendea

4

1 reference

4 February 2018

Inna Cohen

5

1 reference

4 February 2018

Lili Deng

6

1 reference

4 February 2018

James R Sowers

7

1 reference

4 February 2018

Michael V Cutaia

8

1 reference

4 February 2018

Nabil El-Sherif

9

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 September 2003

1 reference

4 February 2018

Biochemical and Biophysical Research Communications

published in

1 reference

4 February 2018

volume

308

1 reference

4 February 2018

issue

4

1 reference

4 February 2018

page(s)

990-994

1 reference

4 February 2018

In vivo evidence that erythropoietin protects neurons from ischemic damage

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901503-1

Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901503-1

Erythropoietin regulates vascular smooth muscle cell apoptosis by a phosphatidylinositol 3 kinase-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901503-1

Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901503-1

Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901503-1

Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901503-1

E1A can provoke G1 exit that is refractory to p21 and independent of activating cdk2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901503-1

Cellular and ionic basis of arrhythmias in postinfarction remodeled ventricular myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901503-1

The functional role of the JAK-STAT pathway in post-infarction remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901503-1

Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901503-1

Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901503-1

Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901503-1

The erythropoietin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901503-1

Activation of protein kinase B/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901503-1

Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901503-1

Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901503-1

Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901503-1

Apoptosis: basic mechanisms and implications for cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901503-1

NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901503-1

Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901503-1

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901503-1

10.1016/S0006-291X(03)01503-1

7 January 2021

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018